生命科学资讯

Financings for Dec. 18, 2025

In the clinic for Dec. 18, 2025

Other news to note for Dec. 18, 2025

Regulatory actions for Dec. 18, 2025

Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial

After year of triumph, Insmed stumbles with chronic rhinosinusitis fail, brings in new asset

Biopharma's winners and losers of 2025

The Illumina-Myome Partnership That Could Save $200 Billion in U.S. Healthcare - Inside Precision Medicine

Insmed’s ‘win streak’ ends as top drug fails study in chronic nasal condition

Gut microbiota promotes immune tolerance at the maternal-fetal interface

GSK pays $17.5M for CAMP4 regulatory RNA deal

Takeda looks to 2026 FDA filing for its Sotyktu rival zasocitinib after phase 3 success

Lilly's obesity pill largely maintains weight lost on injectable GLP-1s

After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3

Takeda's $4B immunology drug achieves first Phase 3 successes

Subcutaneous Rybrevant; Kalaris shares nAMD data; Pyxis disappoints

Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Disease Registry to Advance Real-World E - PharmiWeb.com

Lilly scores again in weight loss with daily GLP-1 orforglipron

Alnylam, INCOG and Novartis expand in US; Ember gets $16.5M Series A

Takeda says $4B TYK2 drug succeeds in large psoriasis studies